Carestream wins FDA clearance for tomosynthesis

By staff writers

January 14, 2020 -- Carestream Health has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its digital tomosynthesis (DT) software, adding a 3D capability to the firm's general radiography technology.

The tomosynthesis technology employs a single sweep of x-ray exposures and streamlines operator workflow by separating DT exposure acquisition from image volume formation, according to the vendor. This enables data to be generated from a series of low-dose x-ray images of an organ that were acquired at the same x-ray exposure but from different angles, Carestream said.

Standard chest x-ray versus digital tomosynthesis
Image courtesy of Carestream.

The DT software is available as an upgradeable option on the vendor's DRX-Evolution Plus digital radiography system.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking